Cargando…
A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is the target for neutralizing antibodies elicited following both infection and vaccination. While extensive research has shown that the receptor binding domain (RBD) and, to a lesser extent, the N-terminal domain (NTD) are the predo...
Autores principales: | Seow, Jeffrey, Khan, Hataf, Rosa, Annachiara, Calvaresi, Valeria, Graham, Carl, Pickering, Suzanne, Pye, Valerie E., Cronin, Nora B., Huettner, Isabella, Malim, Michael H., Politis, Argyris, Cherepanov, Peter, Doores, Katie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365860/ https://www.ncbi.nlm.nih.gov/pubmed/35981534 http://dx.doi.org/10.1016/j.celrep.2022.111276 |
Ejemplares similares
-
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
por: Graham, Carl, et al.
Publicado: (2021) -
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
por: Graham, Carl, et al.
Publicado: (2021) -
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
por: Seow, Jeffrey, et al.
Publicado: (2022) -
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
por: Calvaresi, Valeria, et al.
Publicado: (2023) -
The effect of spike mutations on SARS-CoV-2 neutralization
por: Rees-Spear, Chloe, et al.
Publicado: (2021)